麻豆中文字幕丨欧美一级免费在线观看丨国产成人无码av在线播放无广告丨国产第一毛片丨国产视频观看丨七妺福利精品导航大全丨国产亚洲精品自在久久vr丨国产成人在线看丨国产超碰人人模人人爽人人喊丨欧美色图激情小说丨欧美中文字幕在线播放丨老少交欧美另类丨色香蕉在线丨美女大黄网站丨蜜臀av性久久久久蜜臀aⅴ麻豆丨欧美亚洲国产精品久久蜜芽直播丨久久99日韩国产精品久久99丨亚洲黄色免费看丨极品少妇xxx丨国产美女极度色诱视频www

Scientists develop new form of antibiotic to combat multidrug resistant bacteria

Source: Xinhua| 2018-09-28 12:22:28|Editor: Li Xia
Video PlayerClose

SYDNEY, Sept. 28 (Xinhua) -- A new antibiotic, developed by an Australian led-team of scientists, revealed on Friday, could present a solution to the problem of drug resistant bacteria, which is expected to present an ever increasing concern in the coming century.

The new kind of antibiotic was developed to limit multidrug resistance by targeting and disrupting key elements in bacterial cells, by scientists from Griffith University (GU), in collaboration with colleagues from Queensland University of Technology, the United States' Indiana University and China's Dezhou University.

"We tried to develop a new type of antibiotics that act differently than what we are using right now," Professor Yaoqi Zhou from GU's Institute for Glycomics told Xinhua.

"The way most antibiotics stop key functions in bacteria is that they bind to the surface of an essential protein so that it is unable to perform its normal function."

"Our technique with this new antibiotic approach is different -- instead of binding to the surface of the protein, we disrupt the structure of the protein, which stops it functioning."

In one test Zhou said, the team saw a 500-fold resistance develop to a commonly used antibiotic over 30 days, where as their newly developed antibiotic encountered no developed resistance at all.

Additionally the new drug may be useful in cancer treatment, another area where drug resistance is a major hurdle.

"What we've found in the concept is that it's not only working for antibiotics but should also work for anti-cancer, which also has a lot of problems in terms of drug resistance, also anti-viral - viral infections have a lot of problems with anti-drug resistance," Zhou said.

"So I think this is a concept that should be useful for any other kinds of disease which also has problems with drug resistance issues."

Although still in the early theoretical stage, Zhou is hopeful that the method will progress to animal testing and eventually clinical trials, and provide an answer to what is an increasingly urgent international crisis.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001374987631